These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 27830864)

  • 1. Novel l-prolyl-l-leucylglycinamide (PLG) tripeptidomimetics based on a 2-azanorbornane scaffold as positive allosteric modulators of the D
    Sampaio-Dias IE; Sousa CA; García-Mera X; Ferreira da Costa J; Caamaño O; Rodríguez-Borges JE
    Org Biomol Chem; 2016 Nov; 14(47):11065-11069. PubMed ID: 27830864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, Pharmacological, and Biological Evaluation of MIF-1 Picolinoyl Peptidomimetics as Positive Allosteric Modulators of D
    Sampaio-Dias IE; Silva-Reis SC; García-Mera X; Brea J; Loza MI; Alves CS; Algarra M; Rodríguez-Borges JE
    ACS Chem Neurosci; 2019 Aug; 10(8):3690-3702. PubMed ID: 31347842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and allosteric modulation of the dopamine receptor by peptide analogs of L-prolyl-L-leucyl-glycinamide (PLG) modified in the L-proline or L-proline and L-leucine scaffolds.
    Ferreira da Costa J; Caamaño O; Fernández F; García-Mera X; Sampaio-Dias IE; Brea JM; Cadavid MI
    Eur J Med Chem; 2013 Nov; 69():146-58. PubMed ID: 24013414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of New Potent Positive Allosteric Modulators of Dopamine D
    Sampaio-Dias IE; Reis-Mendes A; Costa VM; García-Mera X; Brea J; Loza MI; Pires-Lima BL; Alcoholado C; Algarra M; Rodríguez-Borges JE
    J Med Chem; 2021 May; 64(9):6209-6220. PubMed ID: 33861612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation of Pro-Leu-Gly-NH2 peptidomimetic positive allosteric modulators of the dopamine D2 receptor into negative modulators.
    Bhagwanth S; Mishra S; Daya R; Mah J; Mishra RK; Johnson RL
    ACS Chem Neurosci; 2012 Apr; 3(4):274-84. PubMed ID: 22860194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of photoaffinity-labeling ligands of the L-prolyl-L-leucylglycinamide binding site involved in the allosteric modulation of the dopamine receptor.
    Fisher A; Mann A; Verma V; Thomas N; Mishra RK; Johnson RL
    J Med Chem; 2006 Jan; 49(1):307-17. PubMed ID: 16392815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and dopamine receptor modulating activity of diketopiperazine peptidomimetics of L-prolyl-L-leucylglycinamide.
    Baures PW; Ojala WH; Costain WJ; Ott MC; Pradhan A; Gleason WB; Mishra RK; Johnson RL
    J Med Chem; 1997 Oct; 40(22):3594-600. PubMed ID: 9357526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric modulation of the dopamine D2 receptor by Pro-Leu-Gly-NH2 peptidomimetics constrained in either a polyproline II helix or a type II beta-turn conformation.
    Raghavan B; Skoblenick KJ; Bhagwanth S; Argintaru N; Mishra RK; Johnson RL
    J Med Chem; 2009 Apr; 52(7):2043-51. PubMed ID: 19271750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and dopamine receptor modulating activity of spiro bicyclic peptidomimetics of L-prolyl-L-leucyl-glycinamide.
    Khalil EM; Ojala WH; Pradhan A; Nair VD; Gleason WB; Mishra RK; Johnson RL
    J Med Chem; 1999 Feb; 42(4):628-37. PubMed ID: 10052970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perturbation Theory/Machine Learning Model of ChEMBL Data for Dopamine Targets: Docking, Synthesis, and Assay of New l-Prolyl-l-leucyl-glycinamide Peptidomimetics.
    Ferreira da Costa J; Silva D; Caamaño O; Brea JM; Loza MI; Munteanu CR; Pazos A; García-Mera X; González-Díaz H
    ACS Chem Neurosci; 2018 Nov; 9(11):2572-2587. PubMed ID: 29791132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific binding of photoaffinity-labeling peptidomimetics of Pro-Leu-Gly-NH2 to the dopamine D2L receptor: evidence for the allosteric modulation of the dopamine receptor.
    Mann A; Verma V; Basu D; Skoblenick KJ; Beyaert MG; Fisher A; Thomas N; Johnson RL; Mishra RK
    Eur J Pharmacol; 2010 Sep; 641(2-3):96-101. PubMed ID: 20639138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and dopamine receptor modulating activity of 3-substituted gamma-lactam peptidomimetics of L-prolyl-L-leucyl-glycinamide.
    Dolbeare K; Pontoriero GF; Gupta SK; Mishra RK; Johnson RL
    J Med Chem; 2003 Feb; 46(5):727-33. PubMed ID: 12593653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, Pharmacological, and Biological Evaluation of 2-Furoyl-Based MIF-1 Peptidomimetics and the Development of a General-Purpose Model for Allosteric Modulators (ALLOPTML).
    Sampaio-Dias IE; Rodríguez-Borges JE; Yáñez-Pérez V; Arrasate S; Llorente J; Brea JM; Bediaga H; Viña D; Loza MI; Caamaño O; García-Mera X; González-Díaz H
    ACS Chem Neurosci; 2021 Jan; 12(1):203-215. PubMed ID: 33347281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-analogs of PLG (L-prolyl-L-leucyl-glycinamide): ex-chiral pool syntheses and dopamine D2 receptor modulating effects.
    Thomas C; Ohnmacht U; Niger M; Gmeiner P
    Bioorg Med Chem Lett; 1998 Oct; 8(20):2885-90. PubMed ID: 9873642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of novel pyridine based PLG tripeptidomimetics.
    Saitton S; Del Tredici AL; Saxin M; Stenström T; Kihlberg J; Luthman K
    Org Biomol Chem; 2008 May; 6(9):1647-54. PubMed ID: 18421399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of peptidomimetic ligands of Pro-Leu-Gly-NH(2) as allosteric modulators of the dopamine D(2) receptor.
    Bhagwanth S; Mishra RK; Johnson RL
    Beilstein J Org Chem; 2013; 9():204-14. PubMed ID: 23400263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric modulation of the dopamine receptor by conformationally constrained type VI beta-turn peptidomimetics of Pro-Leu-Gly-NH2.
    Vartak AP; Skoblenick K; Thomas N; Mishra RK; Johnson RL
    J Med Chem; 2007 Dec; 50(26):6725-9. PubMed ID: 18052024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine receptor modulation by Pro-Leu-Gly-NH2 analogues possessing cyclic amino acid residues at the C-terminal position.
    Johnson RL; Rajakumar G; Mishra RK
    J Med Chem; 1986 Oct; 29(10):2100-4. PubMed ID: 2876103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and evaluation of a PLG tripeptidomimetic based on a pyridine scaffold.
    Saitton S; Del Tredici AL; Mohell N; Vollinga RC; Boström D; Kihlberg J; Luthman K
    J Med Chem; 2004 Dec; 47(26):6595-602. PubMed ID: 15588094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of agonist binding to human dopamine receptor subtypes by L-prolyl-L-leucyl-glycinamide and a peptidomimetic analog.
    Verma V; Mann A; Costain W; Pontoriero G; Castellano JM; Skoblenick K; Gupta SK; Pristupa Z; Niznik HB; Johnson RL; Nair VD; Mishra RK
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1228-36. PubMed ID: 16126839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.